Drugs / 20-hydroxyecdysone
20-hydroxyecdysone
also known as
BIO101 · 20-hydroxy-.alpha.-ecdysone · 20E · Beta-ecdysone · Commisterone · Crustecdyson · Crustecdysone · Ecdysten · +11 more
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT07411378 | Jul 2026 → Jun 2027 expected | muscular atrophy, obesity disorder | Biophytis | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT03452488 | Feb 2017 → Apr 2020 | muscular atrophy | Biophytis | Completed | No outcome recorded |
| Phase 2/32 trials | ||||||
| Phase 2/3 | NCT04827537 | Jan 2021 → Dec 2026 expected | giardiasis | Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan | Active not recruiting | No outcome recorded |
| Phase 2/3 | NCT04472728 | Aug 2020 → Jun 2022 | COVID-19 | Biophytis | Terminated | No outcome recorded |
Evidence & citations 22 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 20-hydroxyecdysone | “BIO101, an investigational new drug, an oral preparation of immediate-release 20-hydroxyecdysone (20E) at ≥ 97% purity.” NCT04472728 ↗ |
| Known as | 20-hydroxy-.alpha.-ecdysone | ChEMBL registry synonym — accepted as the source's own label CHEMBL224128 ↗ |
| Known as | 20E | “BIO101, an investigational new drug, an oral preparation of immediate-release 20-hydroxyecdysone (20E) at ≥ 97% purity.” NCT04472728 ↗ |
| Known as | Beta-ecdysone | ChEMBL registry synonym — accepted as the source's own label CHEMBL224128 ↗ |
| Known as | BIO101 | “Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in” PMID 38545090 ↗ Jan 2024 |
| Known as | Commisterone | ChEMBL registry synonym — accepted as the source's own label CHEMBL224128 ↗ |
| Known as | Crustecdyson | ChEMBL registry synonym — accepted as the source's own label CHEMBL224128 ↗ |
| Known as | Crustecdysone | ChEMBL registry synonym — accepted as the source's own label CHEMBL224128 ↗ |
| Known as | Ecdysten | ChEMBL registry synonym — accepted as the source's own label CHEMBL224128 ↗ |
| Known as | Ecdysteron | ChEMBL registry synonym — accepted as the source's own label CHEMBL224128 ↗ |
| Known as | Ecdysterone | ChEMBL registry synonym — accepted as the source's own label CHEMBL224128 ↗ |
| Known as | Ekdisten | ChEMBL registry synonym — accepted as the source's own label CHEMBL224128 ↗ |
| Known as | Isoinokosterone | ChEMBL registry synonym — accepted as the source's own label CHEMBL224128 ↗ |
| Known as | NSC-629484 | ChEMBL registry synonym — accepted as the source's own label CHEMBL224128 ↗ |
| Known as | Polypodin a | ChEMBL registry synonym — accepted as the source's own label CHEMBL224128 ↗ |
| Known as | Polypodin c | ChEMBL registry synonym — accepted as the source's own label CHEMBL224128 ↗ |
| Known as | Polypodine a | ChEMBL registry synonym — accepted as the source's own label CHEMBL224128 ↗ |
| Known as | Polypodine c | ChEMBL registry synonym — accepted as the source's own label CHEMBL224128 ↗ |
| Known as | The-7 | ChEMBL registry synonym — accepted as the source's own label CHEMBL224128 ↗ |
| Known as | Viticosterone | ChEMBL registry synonym — accepted as the source's own label CHEMBL224128 ↗ |
| Modality | Small molecule | — CHEMBL224128 ↗ |
| Route | Oral | “BIO101 was taken orally” NCT03452488 ↗ |